USP8 modulates ubiquitination of LRIG1 for Met degradation

The Met receptor tyrosine kinase is an attractive target for cancer therapy as it promotes invasive tumor growth. SAIT301 is a novel anti-Met antibody, which induces LRIG1-mediated Met degradation and inhibits tumor growth. However, detailed downstream mechanism by which LRIG1 mediates target protei...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Young Mi, Lee, Saet Byoul, Choi, Jaehyun, Suh, Hye-Young, Shim, Seonhui, Song, Yun-Jeong, Kim, Bogyou, Lee, Ji Min, Oh, Seung Ja, Jeong, Yunju, Cheong, Kwang Ho, Song, Paul H., Kim, Kyung-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021411/
https://www.ncbi.nlm.nih.gov/pubmed/24828152
http://dx.doi.org/10.1038/srep04980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021411/
https://www.ncbi.nlm.nih.gov/pubmed/24828152
http://dx.doi.org/10.1038/srep04980

Ejemplares similares